Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Mucopolysaccharidosis Type I clinical trials
A small indexed set (2 trials) with no open enrollment listed right now.
Corpus placement: #7,188 of 28,707 conditions by registered trial count.
2 US clinical trials · none currently recruiting · #7,188 of 28,707 conditions by registered trial count
Mucopolysaccharidosis Type I: 2 US clinical trials tracked, none currently recruiting.
Mucopolysaccharidosis Type I is the subject of 2 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. The most active sponsor is Masonic Cancer Center, University of Minnesota, running 1 of these trials.
Enrollment posture brief
Registry condition mucopolysaccharidosis-type-i
OPEN 0 | RECR 0% | LATE 0 | EARLY 0 | RANK #7188 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Mucopolysaccharidosis Type I has no open enrollment in this registry pull (2 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Mucopolysaccharidosis Type I on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Mucopolysaccharidosis Type I is recruiting below its size-band peers.
0 of 2 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Indexed trials (enrollment closed)
2 total, page 1 of 1
Evaluation of Intravenous Laronidase Pharmacokinetics Before and After Hematopoietic Cell Transplantation in Patients With Mucopolysaccharidosis Type IH.
Masonic Cancer Center, University of Minnesota
NCT05634512
Longitudinal Studies of Brain Structure and Function in MPS Disorders
University of Minnesota
NCT01870375
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Mucopolysaccharidosis Type I records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Mucopolysaccharidosis Type I trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Mucopolysaccharidosis Type I page
2 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Mucopolysaccharidosis Type I trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Masonic Cancer Center, University of Minnesota sponsors the most Mucopolysaccharidosis Type I trials on record, review their full trial history before evaluating a specific study. See Masonic Cancer Center, University of Minnesota's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Mucopolysaccharidosis Type I condition card totals 2 registered trials; most-linked intervention Laronidase therapy and a stem cell transplant; top US site state Minnesota. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.